ATLANTA, Ga. — UPS (NYSE: UPS) announced that it has completed its acquisition of Andlauer Healthcare Group Inc. (TSX: AND), a leading North American supply chain management company headquartered in Canada that provides specialized cold chain transportation and third-party logistics solutions for the healthcare industry. Under the terms of the agreement, Andlauer shareholders received CAD $55.00 per share in cash, for a total transaction value of approximately CAD $2.2 billion (USD $1.6 billion).
The acquisition expands UPS Healthcare’s cold chain and pharmaceutical logistics capabilities across North America and globally, enhancing the company’s ability to provide end-to-end visibility, quality assurance, and faster delivery for temperature-sensitive and high-value treatments.
“At UPS Healthcare, we are relentlessly focused on quality, improving patient outcomes, and advancing healthcare delivery, and we are thrilled that Andlauer Healthcare Group and its talented employees share that focus,” said Kate Gutmann, executive vice president and president of International, Healthcare and Supply Chain Solutions for UPS. “We will provide industry-leading services to our global customers, built on a foundation of quality, precision, and speed — all designed to help manage high-value, temperature-sensitive treatments.”
Following the acquisition, Michael Andlauer, founder and CEO of Andlauer Healthcare Group, will lead UPS Canada Healthcare and AHG. In his new role, he will focus on expanding the companies’ specialized logistics capabilities and delivering advanced solutions to meet growing global healthcare demands.
The acquisition underscores UPS’s commitment to expanding its position as a global leader in complex healthcare logistics, providing quality-focused and patient-driven solutions to pharmaceutical, biotech, and medical device customers worldwide.
